Friday
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
Location: Grand Ballroom East, 3rd Floor
Moderators:Klaus D. Mathias, MD / Sumaira Macdonald, MD, PhD  
SESSION 80 SCHEDULE
MESH COVERED STENTS
7:53 AM - 7:58 AM Long-Term Results Of Micromesh Stents Show Their Value In Carotid Artery Stenting (CAS): Are There Limitations: Do The Differences In The 3 Micromesh Stents Matter
  Presenter(s):D. Christopher Metzger, MD  / Max Amor, MD  
Location: Grand Ballroom East, 3rd Floor
7:59 AM - 8:04 AM Update On The MicroNet-Covered Stents (C-Guard From InspireMD) For CAS: Value Overall, With High-Risk Lesions And With TCAR: Are There Any Downsides
  Presenter(s):Piotr Musialek, MD, DPhil / Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
8:05 AM - 8:10 AM New Multicenter Data Showing The Long-Term Value Of The C-Guard MicroNet Mesh Covered Stent For CAS In High Risk Carotid Lesions (Thrombotic, Calcified And Symptomatic) From The FLOW-GUARD And Other Trials
  Presenter(s):D. Christopher Metzger, MD  / Piotr Musialek, MD, DPhil  
Location: Grand Ballroom East, 3rd Floor
8:11 AM - 8:16 AM Results From A Multicenter Italian Study Of The C-Guard Micromesh Stent For CAS: Advantages And Complications
  Presenter(s):Francesco Speziale, MD / Gianmarco de Donato, MD / Wassim Mansour, MD / Pasqualino Sirignano, MD / Carlo Setacci, MD  
Location: Grand Ballroom East, 3rd Floor
8:17 AM - 8:22 AM Real-World Results Of ~2,000 Patients Treated With The Roadsaver (Terumo) Dual-Layer Micro Mesh Carotid Stent: Advantages And Limitations
  Presenter(s):Stefan Mueller-Huelsbeck, MD  
Location: Grand Ballroom East, 3rd Floor
8:23 AM - 8:28 AM Panel Discussion
TCAR RELATED TOPICS
8:29 AM - 8:34 AM DEBATE: TCAR Versus CEA (Carotid Endarterectomy): 3-Year Results From A Large Propensity Matched VQI-Medicare Database Show Similar Stroke, And Death Rates At 3 Years For Symptomatic And Asymptomatic Patients: At 3-Years: TCAR Can Replace CEA More Widely
  Presenter(s):Mahmoud B. Malas, MD, MHS / Marc L. Schermerhorn, MD / Vik S. Kashyap, MD  
Location: Grand Ballroom East, 3rd Floor
8:35 AM - 8:40 AM DEBATE: Not So Fast: TCAR Is Not Yet Ready To Replace CEA Widely: We Still Need Further Proof And More Studies Possibly Including An RCT
  Presenter(s):Bruce A. Perler, MD, MBA  
Location: Grand Ballroom East, 3rd Floor
8:41 AM - 8:46 AM How Adjunctive Techniques (EEG And IVUS) Help With TCAR And Decrease Stroke Rates
  Presenter(s):Todd R. Vogel, MD, MPH  
Location: Grand Ballroom East, 3rd Floor
8:47 AM - 8:52 AM DEBATE: TCAR Is Better Than TFCAS And Brachial/Radial Access For CAS
  Presenter(s):Marc L. Schermerhorn, MD / Mahmoud B. Malas, MD, MHS  
Location: Grand Ballroom East, 3rd Floor
8:53 AM - 8:58 AM DEBATE: Not So: TCAR Is No Better And Is More Costly Than TFCAS And Brachial/Radial Access CAS If One Has Appropriate Skills
  Presenter(s):D. Christopher Metzger, MD  / William A. Gray, MD  
Location: Grand Ballroom East, 3rd Floor
8:59 AM - 9:04 AM Should TCAR Replace Most CEAs Or Is CEA Still The Gold Standard For Most Cases Requiring Invasive Treatment Based On A Cost Analysis
  Presenter(s):Michel Makaroun, MD  
Location: Grand Ballroom East, 3rd Floor
9:05 AM - 9:10 AM TCAR Is Safe In Recently Symptomatic Patients And Those With Contralateral Carotid Occlusions: Why It Should Be The Procedure Of Choice In Those Conditions
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
9:11 AM - 9:16 AM Pre-Dilatation And Post Dilatation Strategies For TCAR: Do They Differ From TFCAS: Does Patient Sex Affect TCAR Outcomes
  Presenter(s):Vik S. Kashyap, MD  
Location: Grand Ballroom East, 3rd Floor
9:17 AM - 9:24 AM Panel Discussion
9:24 AM - 9:34 AM Break – Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 80
previous next